Connection
Larry Moreland to Follow-Up Studies
This is a "connection" page, showing publications Larry Moreland has written about Follow-Up Studies.
|
|
Connection Strength |
|
|
|
|
|
0.221 |
|
|
|
-
Curtis JR, Lander PH, Moreland LW. Swallowing difficulties from "DISH-phagia". J Rheumatol. 2004 Dec; 31(12):2526-7.
Score: 0.033
-
Moreland L. Adalimumab in rheumatoid arthritis. Curr Rheumatol Rep. 2004 Oct; 6(5):333-4.
Score: 0.033
-
Moreland L. Infliximab in rheumatoid arthritis. Curr Rheumatol Rep. 2004 Oct; 6(5):334-5.
Score: 0.033
-
Mikuls T, Moreland L. Predicting outcomes in early rheumatoid arthritis. Curr Rheumatol Rep. 2002 Jun; 4(3):193-4.
Score: 0.028
-
Kermani TA, Sreih AG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Warrington KJ, Ytterberg SR, Merkel PA. Evaluation of damage in giant cell arteritis. Rheumatology (Oxford). 2018 02 01; 57(2):322-328.
Score: 0.021
-
Charles-Schoeman C, Wang X, Lee YY, Shahbazian A, Navarro-Mill?n I, Yang S, Chen L, Cofield SS, Moreland LW, O'Dell J, Bathon JM, Paulus H, Bridges SL, Curtis JR. Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheumatol. 2016 Mar; 68(3):577-86.
Score: 0.018
-
Moreland LW, Pratt PW, Bucy RP, Jackson BS, Feldman JW, Koopman WJ. Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts. Arthritis Rheum. 1994 Jun; 37(6):834-8.
Score: 0.016
-
Racovan M, Walitt B, Collins CE, Pettinger M, Parks CG, Shikany JM, Wactawski-Wende J, Manson JE, Moreland L, Wright N, Jackson R, Howard BV. Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women's Health Initiative Calcium plus Vitamin D trial. Rheumatol Int. 2012 Dec; 32(12):3823-30.
Score: 0.013
-
Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Li T, Teng J, Becker JC, Westhovens R. Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum. 2008 Apr; 58(4):953-63.
Score: 0.010
-
Khanna D, Furst DE, Hays RD, Park GS, Wong WK, Seibold JR, Mayes MD, White B, Wigley FF, Weisman M, Barr W, Moreland L, Medsger TA, Steen VD, Martin RW, Collier D, Weinstein A, Lally EV, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ. Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis. 2006 Oct; 65(10):1325-9.
Score: 0.009
-
Clements PJ, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Wong WK. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum. 2004 Feb; 33(4):249-63.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|